SPRED1 deletion confers resistance to MAPK inhibition in melanoma

Functional evaluation of genetic lesions can discover a role in cancer initiation and progression and help develop novel therapeutic strategies. We previously identified the negative MAPK regulator SPRED1 as a novel tumor suppressor in KIT-driven melanoma. Here, we show that SPRED1 is also frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ablain, Julien, Liu, Sixue, Moriceau, Gatien, Lo, Roger S., Zon, Leonard I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927430/
https://www.ncbi.nlm.nih.gov/pubmed/33306107
http://dx.doi.org/10.1084/jem.20201097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927430/
https://www.ncbi.nlm.nih.gov/pubmed/33306107
http://dx.doi.org/10.1084/jem.20201097

Ejemplares similares